VERVE-101 Shows Promise in Treating HeFH, Phase 1b Study Results Show

Heterozygous familial hypercholesterolemia (HeFH) can be difficult to control on available standard-of-care cholesterol-lowering medications. Therapeutic interventions are needed to reduce high LDL cholesterol levels and improve health and quality-of-life for…

Continue Reading VERVE-101 Shows Promise in Treating HeFH, Phase 1b Study Results Show
These Clinical Trials Could be Game Changers in the Latter Half of 2023
source: shutterstock.com

These Clinical Trials Could be Game Changers in the Latter Half of 2023

In a story from BioPharma Dive, a number of high-profile clinical trials are under way that could see conclusive results by the end of 2023. While some of these are…

Continue Reading These Clinical Trials Could be Game Changers in the Latter Half of 2023
Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
source: pixabay.com

Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers

Researchers in Canada have just released positive results from their heterozygous familial hypercholesterolemia (HeFH) clinical trial. This investigation was examining the effect of Repatha on teenagers with the condition. The trial…

Continue Reading Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
Fighting FH and LDL Cholesterol with Valuable New Drug
https://pixabay.com/en/dollar-money-currency-trade-1974694/

Fighting FH and LDL Cholesterol with Valuable New Drug

We’ve all heard the expression, “Beauty is in the eye of the beholder.” How about another cliché? “One man’s trash is another man’s treasure.” These trite statements do, in fact,…

Continue Reading Fighting FH and LDL Cholesterol with Valuable New Drug

FH Patients Win Big In Innovative New “Pay to Perform” Deal

So here’s a nice antidote to all those stories about greedy pharma execs soaking patients for ultra-expensive treatments. There’s a new approach to contrpay-acting between insurance companies and pharmaceutical companies…

Continue Reading FH Patients Win Big In Innovative New “Pay to Perform” Deal